SL-327
目录号 : GC15359A selective MEK1/2 inhibitor
Cas No.:305350-87-2
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Kinase experiment [1]: | |
Binding assays |
Lysates (100 μg/sample) were incubated with 10 μg of an anti-MAPKAP kinase-2 antibody on a rocking platform at 4°C. After 3 h, 50 μl of a protein A/G-agarose slurry was added, and tubes were rocked for another 1 h at 4°C. Agarose beads were pelleted by centrifugation at 1500 × g for 5 min., washed three times with lysis buffer and washed once with 20 mM Hepes, pH 7.0 buffer. Immunoprecipitations were resuspended in 75 μl of kinase assay buffer (20 mM Hepes, pH 7.0, 5 mM 2-mercaptoethanol, 10 mM MgCl2, 0.1 mg/ml bovine serum albumin, containing 2 μg of hsp27. Kinase reactions were initiated by the addition of 10 μM ATP plus 10 μCi of [γ-33P]ATP and incubated at 25°C for 30 min. Reactions were terminated by the addition of Laemmli SDS sample buffer, boiled for 5 min, electrophoresed on a 12% Tris-glycine gel, dried, and quantitated using a Molecular Dynamics phosphorimager. |
Animal experiment [2,3]: | |
Animal models |
Adult male CD-1 mice, Morphine-pretreated rats |
Preparation method |
The solubility of this compound in DMSO is >16.8mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37 ℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months. |
Dosage form |
50 mg/kg, diluted 1:1 in water and DMSO immediately before the injection, Intraperitoneal injection, |
Application |
In adult male CD-1 mice, SL-327 (50 mg/kg, i.p.) inhibited Pp-ERK immunostaining in the nuclei of the cells induced by cocaine. SL-327 (50 mg/kg, i.p.) pretreatment inhibited c-Fos expression in nuclear and inhibited activation of ERK within all the amygdala. In morphine-pretreated rats, SL-327 (20 mg/kg, i.p.) increased (58%) the expression of morphine-induced psychomotor sensitization (SW3) and fully prevented the upregulation of p-PEA-15, p-FADD, and p-Akt1 at SW3. |
Other notes |
Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
References: [1]. Scherle P A, Ma W, Lim H, et al. Regulation of Cyclooxygenase-2 Induction in the Mouse Uterus During Decidualization AN EVENT OF EARLY PREGNANCY[J]. Journal of Biological Chemistry, 2000, 275(47): 37086-37092. [2]. Radwanska K, Caboche J, Kaczmarek L. Extracellular signal‐regulated kinases (ERKs) modulate cocaine‐induced gene expression in the mouse amygdala[J]. European Journal of Neuroscience, 2005, 22(4): 939-948. [3] Ramos-Miguel A, Esteban S, García-Sevilla J A. The time course of unconditioned morphine-induced psychomotor sensitization mirrors the phosphorylation of FADD and MEK/ERK in rat striatum: role of PEA-15 as a FADD-ERK binding partner in striatal plasticity[J]. European Neuropsychopharmacology, 2010, 20(1): 49-64. |
SL-327 is a selective inhibitor of MEK1 and MEK2 with IC50 values of 0.18 and 0.22μM, respectively.
MEK1 and MEK2 (ERK) are a kinase enzyme which phosphorylate mitogen-activated protein kinase (MAPK). Extracellular signal-regulated kinase (ERK) activity is essential for the acquisition of associative learning tasks.
In adult male CD-1 mice, SL-327 inhibited Pp-ERK immunostaining in the nuclei of the cells induced by cocaine. SL-327 pretreatment inhibited c-Fos expression in nuclear and inhibited activation of ERK within all the amygdala, namely LA, BLA, BMP, Ce and MePD [1]. In morphine-pretreated rats, SL-327 increased (58%) the expression of morphine-induced psychomotor sensitization (SW3) and fully prevented the upregulation of p-PEA-15, p-FADD, and p-Akt1 at SW3 [2]. In adult male DBA/2J mice, SL-327 significantly reduced pERK levels by 40% in both the motor cortex and dorsal striatum [3]. In rat model, SL-327 inhibited MAPK/ERK cascade, which prevented LTP-dependent gene induction and CREB and Elk-1 phosphorylation, resulting in rapidly decaying LTP [4].
References:
[1]. Radwanska K, Caboche J, Kaczmarek L. Extracellular signal-regulated kinases (ERKs) modulate cocaine-induced gene expression in the mouse amygdala. Eur J Neurosci, 2005, 22(4): 939-948.
[2]. Ramos-Miguel A, Esteban S, García-Sevilla JA. The time course of unconditioned morphine-induced psychomotor sensitization mirrors the phosphorylation of FADD and MEK/ERK in rat striatum: role of PEA-15 as a FADD-ERK binding partner in striatal plasticity. Eur Neuropsychopharmacol, 2010, 20(1): 49-64.
[3]. Groblewski PA, Franken FH, Cunningham CL. Inhibition of extracellular signal-regulated kinase (ERK) activity with SL327 does not prevent acquisition, expression, and extinction of ethanol-seeking behavior in mice. Behav Brain Res, 2011, 217(2): 399-407.
[4]. Davis S, Vanhoutte P, Pages C, et al. The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J Neurosci, 2000, 20(12): 4563-4572.
Cas No. | 305350-87-2 | SDF | |
化学名 | (Z)-3-amino-3-(4-aminophenyl)sulfanyl-2-[2-(trifluoromethyl)phenyl]prop-2-enenitrile | ||
Canonical SMILES | C1=CC=C(C(=C1)C(=C(N)SC2=CC=C(C=C2)N)C#N)C(F)(F)F | ||
分子式 | C16H12F3N3S | 分子量 | 335.35 |
溶解度 | ≥ 16.75mg/mL in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.982 mL | 14.9098 mL | 29.8196 mL |
5 mM | 0.5964 mL | 2.982 mL | 5.9639 mL |
10 mM | 0.2982 mL | 1.491 mL | 2.982 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。